Impinj, Inc. (NASDAQ:PI) represented a move of 0.23 percent or $-0.26 per share and closed its previous day trading session at $12.91. 688231 Shares were traded in the last trading session with an Average Volume of 845.29 Million Shares. The stock currently has a Market Capitalization of 265.69 Million.
Impinj, Inc. is a provider of referral and information network radio frequency identification solutions to the retail, pharmaceutical, healthcare, food and beverage and other industries. The company’s products include Indy Reader Chips which consists of integrated radio chips and supporting SDKs; Monza Tag Chips, which deliver memory options and extended features to RFID tags and Speedway fixed RFID readers and antennas for RFID-based information. Impinj, Inc. is based in Seattle, Washington.
The stock traded between $11.31 and $60.85 over 1-Year time period showing its price to sales ratio of 2.01. Impinj, Inc. (NASDAQ:PI) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-39.94 and 200-Day Simple Moving Average of $-63.55. Its Price to Free Cash Flow is 0 and Price to Book of 2.14.
Analyst’s recommended the stock as 2.9 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Impinj, Inc. (NASDAQ:PI) reported its Actual EPS of $-0.08/share. The analysts offering Earnings Estimates for the company were believing that Impinj, Inc. could bring EPS of $-0.03/share. The difference between Actual EPS and Estimated EPS was -0.05 Percent. Thus showing an Earnings Surprise of -166.7 Percent.
Cardiovascular Systems Inc. (NASDAQ:CSII)
In the last trading session, Cardiovascular Systems Inc. (NASDAQ:CSII) added its value by -3.66% closing at the price of $21.05. The stock currently has market capitalization of 715.07 Million, with average volume of 282.45 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Cardiovascular Systems Inc. (NASDAQ:CSII) is showing beta of 2.07. This particular value of beta suggests that Cardiovascular Systems Inc. (NASDAQ:CSII) has historically moved 207% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Cardiovascular Systems Inc. (NASDAQ:CSII) is at $-0.1.
The stock currently has RSI of 28.71. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360° Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360° removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its orbital technology to address the growing market need of providing a safer more effective atherectomy device.
Cardiovascular Systems Inc. (NASDAQ:CSII) topped its 52-week high price of $33.11 on 07/20/17 and 52-Week Low Price of $20.58 on 02/14/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 8.34% and monthly volatility of 4.72% respectively.